Search - tctmd.com

Displaying 1 - 6 of 6

Sort: Relevancy | Date

Presentation TCT 2014

Delayed coverage of drug eluting stents after interventional revascularization of chronic total occlusions assessed by optical coherence tomography: the ALSTER-OCT-CTO registry

Presenter: Christian Heeger

September 16, 2014

Presentation

Randomized Comparison of Sirolimus-eluting (SES) and Everolimus-eluting (EES) Coronary Stents in the Treatment of Total Coronary Occlusions

Presenter: 13956|Raul Moreno

February 24, 2013

Presentation TCT 2012

TCT-75. Lumen Enlargement of the Coronary Segments Located Distal to Chronic Total Occlusions Successfully Treated with Drug-Eluting Stents at Follow-up

Presenter: Josep Gomez-Lara

October 23, 2012

Presentation TCT 2012

After CTO Recanalization, What Is the Role of Drug-Eluting Devices, Covered Stents, Etc?

Presenter: Thomas Zeller

October 23, 2012

Presentation TCT 2012

ACE-CTO: Angiographic Follow-up After Everolimus-eluting Stents in CTO

Presenter: Emmanouil Brilakis

October 22, 2012

Presentation TCT 2012

Does Diabetes Mellitus Impact on Clinical Outcomes following Chronic Total Occlusion Intervention with Drug-eluting Stents?

Presenter: Amro Elnagar, Seung Woon Rha, Byoung Geol Choi, Sung Il Im, SunWon Kim, Jin Oh Na, Seong Woo Han, Cheol Ung Choi, Hong Euy Lim, Jin Won Kim, Eung Ju Kim, Chang Gyu Park, Hong Seog Seo, Dong Joo Oh

January 03, 2012

Advertisement

Delayed coverage of drug eluting stents after interventional revascularization of chronic total occlusions assessed by optical coherence tomography: the ALSTER-OCT-CTO registry

Randomized Comparison of Sirolimus-eluting (SES) and Everolimus-eluting (EES) Coronary Stents in the Treatment of Total Coronary Occlusions

TCT-75. Lumen Enlargement of the Coronary Segments Located Distal to Chronic Total Occlusions Successfully Treated with Drug-Eluting Stents at Follow-up

After CTO Recanalization, What Is the Role of Drug-Eluting Devices, Covered Stents, Etc?

ACE-CTO: Angiographic Follow-up After Everolimus-eluting Stents in CTO

Does Diabetes Mellitus Impact on Clinical Outcomes following Chronic Total Occlusion Intervention with Drug-eluting Stents?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content